✦ LIBER ✦

Application of thermoregulatory modeling to predict core and skin temperatures in firefighters

✍ Scribed by Kim, Jung-Hyun; Williams, W. Jon; Coca, Aitor; Yokota, Miyo

Book ID: 122437277
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 271 KB
Volume: 43
Category: Article
ISSN: 0169-8141
DOI: 10.1016/j.ergon.2012.11.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temperature and burn injury prediction o

Temperature and burn injury prediction of human skin exposed to microwaves: a model analysis

✍ Sukru Ozen; Selcuk Helhel; Suleyman Bilgin 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 485 KB

Interrelations of vasoconstrictor sympat

Interrelations of vasoconstrictor sympathetic outflow to skin and core temperature during unilateral sole heating in humans

✍ Daisaku Michikami; Satoshi Iwase; Atsunori Kamiya; Fu Qi; Tadaaki Mano; Akio Suz 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A Three-Dimensional Finite Element Model

A Three-Dimensional Finite Element Model of the Transibial Residual Limb and Prosthetic Socket to Predict Skin Temperatures

✍ Peery, J.T.; Klute, G.K.; Blevins, J.J.; Ledoux, W.R. 📂 Article 📅 2006 🏛 IEEE 🌐 English ⚖ 574 KB

Temperature Changes in the Conjunctiva i

Temperature Changes in the Conjunctiva in Relation to Application of Heat and Cold to the Skin

✍ Gowen, G. Howard 📂 Article 📅 1935 🏛 Elsevier Science 🌐 English ⚖ 427 KB

The application and limitations of mathe

The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranes

✍ Gary P. Moss; Yi Sun; Simon C. Wilkinson; Neil Davey; Rod Adams; Gary P. Martin; 📂 Article 📅 2011 🏛 Pharmaceutical Press 🌐 English ⚖ 649 KB

Application of pharmacokinetic–pharmacod

Application of pharmacokinetic–pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice

✍ Evelyn D. Lobo; David M. Soda; Joseph P. Balthasar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

We have shown that intravenous (i.v.) administration of anti-methotrexate (MTX) antibodies (AMAb) reduces the systemic exposure of intraperitoneal (i.p.) MTX therapy, and we have proposed that AMAb effects on MTX systemic exposure would allow a reduction in MTX-induced systemic toxicity (i.e., produ